Phospho-SYT1 (Thr202) Antibody

Shipped with Ice Packs
In Stock

Description

Applications

  • ELISA: Detects phosphorylated SYT1 in lysates or immunogen-specific assays .

  • WB: Identifies phosphorylated SYT1 in cell lysates, with validated specificity via phosphopeptide blocking .

  • IHC: Stains SYT1-positive neurons in paraffin-embedded tissues, with reduced signal upon phosphopeptide competition .

  • ICC: Localizes phosphorylated SYT1 in synaptic vesicles and active zones .

Validation Data

  • Western Blot: Detects a ~48 kDa band corresponding to SYT1 in forskolin-treated 293 cells .

  • ELISA: Shows high specificity for phosphorylated immunogen (IC₅₀ < 10 ng/mL) .

SYT1 Function and Phosphorylation

SYT1 acts as a calcium sensor in synaptic vesicle fusion, binding acidic phospholipids in a Ca²⁺-dependent manner . Phosphorylation at Thr202 modulates its interactions with syntaxin, neurexin, and AP2, influencing vesicle priming and neurotransmitter release . This modification is critical for presynaptic plasticity and synaptic efficiency .

Product Comparisons

VendorSKUPrice (100 µL)Species ReactivityApplications
AFG ScientificA52101-100ul$399Human, Mouse, RatELISA, WB, IHC
Boster BioA02314T202N/AHuman, Mouse, RatELISA, WB, IHC
St John’s LabsSTJA0003791N/ABroad (including Zebrafish)WB, ICC

Research Insights

  • Neurotransmitter Release: Phospho-SYT1 (Thr202) is enriched at active zones, correlating with Ca²⁺ influx and vesicle fusion .

  • Botulinum Toxin Interaction: SYT1’s vesicular domain (residues 32–53) binds BoNT/G, with Thr202 phosphorylation enhancing toxin binding .

  • Dendrite Formation: SYT1’s phosphorylation state regulates melanocyte dendrite outgrowth .

This antibody remains a cornerstone tool in studying SYT1’s role in synaptic plasticity and neurodegenerative diseases. Its cross-reactivity across species and validated applications make it a versatile choice for diverse experimental systems.

Product Specs

Form
Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Lead Time
Typically, we can ship your orders within 1-3 business days of receiving them. Delivery times may vary depending on the shipping method and destination. For specific delivery time estimates, please contact your local distributor.
Synonyms
DKFZp781D2042 antibody; FLJ42519 antibody; p65 antibody; SVP65 antibody; Synaptotagmin 2 antibody; Synaptotagmin I antibody; Synaptotagmin II antibody; Synaptotagmin-1 antibody; SYT antibody; Syt1 antibody; SYT1_HUMAN antibody; Syt2 antibody; SytI antibody
Target Names
Uniprot No.

Target Background

Function
Synaptotagmin 1 (SYT1) is a calcium sensor that plays a critical role in triggering neurotransmitter release at the synapse. It is believed to have a regulatory role in membrane interactions during the trafficking of synaptic vesicles at the active zone of the synapse. SYT1 exhibits a specific binding affinity for acidic phospholipids, requiring the presence of both an acidic head group and a diacyl backbone. Studies have also demonstrated a calcium-dependent interaction between SYT1 and putative receptors for activated protein kinase C. Notably, SYT1 can bind to at least three additional proteins in a calcium-independent manner, including neurexins, syntaxin, and AP2. SYT1 has been implicated in dendrite formation by melanocytes.
Gene References Into Functions
  1. Recent research replicates the previously suggested association of the SYT1-rs2251214 SNP with Attention-Deficit/Hyperactivity Disorder (ADHD) in adults. PMID: 28130000
  2. Molecular dynamics simulations have revealed that all peptides induced significant rigidity in SYT1 by binding in the cleft of the C2A-C2B interface. This binding event suppresses the protein motion associated with the conformational change of SYT1 from its closed form to its open form. PMID: 29019108
  3. While both otoferlin and synaptotagmin bind membrane fusion SNARE proteins, only otoferlin interacts with the L-type calcium channel Cav1.3. PMID: 28696301
  4. Circular oligomerization is an inherent property of SYT1. PMID: 28850328
  5. Research suggests that the reduction in synaptotagmin 1 levels and presenilin 1-synaptotagmin 1 interactions in Alzheimer's Disease (AD) brain may provide a molecular basis for the pathogenic presenilin 1 conformation. PMID: 28193235
  6. Findings indicate that extended Synaptotagmin 1 (E-Syt1), along with its related protein E-Syt3, negatively modulates viral release into the extracellular milieu, cell-to-cell viral spread, and viral entry, processes that involve membrane fusion events. These E-Syt proteins impact the formation of virus-induced syncytia. These findings suggest the modulation of the viral fusion machinery by the E-Syt family of proteins. PMID: 29046455
  7. Utilizing electron microscopy combined with targeted mutations, researchers demonstrate that under physiologically relevant conditions, both the Syt1 ring assembly and its rapid disruption by calcium involve the well-established functional surfaces on the C2B domain that are crucial for synaptic transmission. PMID: 27434670
  8. This study found that the cerebrospinal fluid (CSF) levels of synaptotagmin-1 were consistently elevated in patients with dementia due to Alzheimer's disease. PMID: 27716408
  9. The SYT-SSX fusion is associated with synovial sarcoma. PMID: 27621063
  10. Extended synaptotagmins (E-Syts) are endoplasmic reticulum (ER) proteins that function as phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2)- and calcium-regulated tethers to the plasma membrane. PMID: 27065097
  11. Data suggest that small protein sequence changes in the calcium-binding loops of the C2 domains may lead to differences in binding kinetics between Syt-1 and Syt-7 isoforms. PMID: 27997124
  12. These findings identify SYT1 as a novel calcium-sensitive presenilin 1 (PS1) modulator that could regulate synaptic Abeta, opening avenues for novel and selective synapse-targeting therapeutic strategies. PMID: 27036734
  13. One-step reverse transcriptase real-time PCR for the detection of SYT-SSX transcripts is feasible as an aid in confirming the diagnosis of synovial sarcoma. PMID: 27126659
  14. Membrane tethering by E-Syt1 (ER to plasma membrane) and by synaptotagmin (secretory vesicles to plasma membrane) undergo similar regulation by plasma membrane lipids and cytosolic calcium. PMID: 26202220
  15. A dominant negative de novo SYT1 missense variant (I368T) altered the kinetics of synaptic vesicle endocytosis and caused an early-onset dyskinetic movement disorder, severe motor delay, and profound cognitive impairment. PMID: 25705886
  16. Data suggests that calcium-dependent phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2)-binding proteins (such as SYT1, protein kinase C alpha (PRKCA), and annexin A2 (ANXA2)) interactions with membrane microdomains are tightly regulated. [REVIEW] PMID: 25233429
  17. Whole genome analyses of a well-differentiated liposarcoma reveals novel SYT1 and DDR2 rearrangements. PMID: 24505276
  18. Hydrophobic interactions play a key role in SYT1 binding botulinum neurotoxin DC. PMID: 23932591
  19. Structural insights into the calcium and PI(4,5)P2 binding modes of the C2 domains of rabphilin 3A and synaptotagmin 1. PMID: 24302762
  20. Synaptotagmin-1 is involved in a rapid vesicular calcium sequestration through a calcium/hydrogen antiport. PMID: 23607712
  21. PRIP inhibits regulated exocytosis through the interaction of its C2 domain with syntaxin 1 and SNAP-25, potentially competing with accessory proteins such as synaptotagmin I and by directly inhibiting trans-SNARE complex formation. PMID: 23341457
  22. Characterization of negative coupling interaction between the C2 domains of Syt I. PMID: 23071627
  23. The mechanistic basis for the C2A domain of synaptotagmin I's response to calcium and cellular function stems from marginal stability and ligand-induced redistributions of protein conformers. PMID: 22853901
  24. The membrane dissociation of SYT7 C2A domain but not SYT1 C2A domain is slowed by sodium sulfate and trehalose, solutes that enhance the hydrophobic effect. PMID: 22966849
  25. Together with synaptotagmin 1, complexin synchronizes and stimulates rapid fusion of accumulated docked vesicles in response to physiological calcium concentrations. PMID: 22705946
  26. The calcium binding site to the C2A domain of SYT1 has been identified; this SYT1 domain activates exocytosis of secretory vesicles during neurotransmitter release. PMID: 22475172
  27. Association between serum creatinine level and polymorphisms in the collagen type XXII alpha 1 (COL22A1) gene, on chromosome 8, and in the synaptotagmin-1 (SYT1) gene, on chromosome 12. PMID: 20222955
  28. NMR characterization of copper and lipid interactions of the C2B domain of synaptotagmin I-relevance to the non-classical secretion of the human acidic fibroblast growth factor (hFGF-1). PMID: 19835837
  29. Intestinal epithelial SYT 1 plays a significant role in cAMP-stimulated endocytosis of apical NHE3 through cAMP-dependent phosphorylation of S605, which is required for NHE3 and SYT 1 association. PMID: 19926819
  30. Synaptotagmin-I-expressing neuroblastoma cells require gangliosides for Botulinum neurotoxin A activity. PMID: 12089155
  31. Both synaptotagmins I and II can interact with the syntaxin/synaptosomal-associated protein of 25 kDa (SNAP-25) dimer. PMID: 14709554
  32. SYT I mediates cAMP- and calcium-induced endocytosis of NHE3 through cargo recognition of NHE3 and subsequent recruitment of AP2-clathrin assembly, which is necessary for membrane endocytosis. PMID: 17307723
  33. The shared interface between C2A and C2B is stabilized by a network of interactions between residues on the C-terminal alpha-helix of the C2B domain and residues on loops 1-3 of the calcium-binding region of C2A. PMID: 17956130
  34. These findings provide new information regarding the epileptogenesis of refractory epilepsy, and suggest that Synaptotagmin I might be involved in human refractory epilepsy. PMID: 18779938
  35. Mechanical stability of the C2A and C2B domains of human SYT1. PMID: 19186144

Show More

Hide All

Database Links

HGNC: 11509

OMIM: 185605

KEGG: hsa:6857

STRING: 9606.ENSP00000261205

UniGene: Hs.310545

Involvement In Disease
A SYT1 rare mutation has been found in a child with a severe neuro-developmental disorder. The individual harboring this variant shows early onset dyskinetic movement disorder, severe motor delay and profound cognitive impairment, suggesting that SYT1 may play a role in the pathogenesis of this neuro-developmental disorder.
Protein Families
Synaptotagmin family
Subcellular Location
Cytoplasmic vesicle, secretory vesicle membrane; Single-pass membrane protein. Cytoplasmic vesicle, secretory vesicle, synaptic vesicle membrane; Single-pass membrane protein. Cytoplasmic vesicle, secretory vesicle, chromaffin granule membrane; Single-pass membrane protein. Cytoplasm.
Tissue Specificity
Expressed in melanocytes.

Q&A

Basic Research Questions

  • What is Synaptotagmin-1 and why is phosphorylation at Thr202 significant?

Synaptotagmin-1 (SYT1) is a synaptic vesicle transmembrane protein that functions as the primary calcium sensor for triggering synchronous neurotransmitter release at synapses. The protein senses calcium influx via its tandem C2-domains, which is essential for the neurotransmitter release process . SYT1 plays a critical dual role in both exocytosis and endocytosis of synaptic vesicles .

Phosphorylation at Thr202 is particularly significant because it serves as a key regulatory mechanism for SYT1's functionality. This post-translational modification is catalyzed by multiple protein kinases and plays a crucial role in modulating SYT1's ability to influence both the exocytotic and endocytotic components of synaptic transmission . The phosphorylation state at this specific residue may determine how efficiently SYT1 responds to calcium signals and regulates neurotransmitter release kinetics.

  • How does Phospho-SYT1 (Thr202) differ from total SYT1 in cellular function?

The distinction between phosphorylated SYT1 at Thr202 and total SYT1 represents an important regulatory mechanism in neuronal function. Phosphorylation at Thr202 appears to modulate SYT1's functionality in both exocytosis and endocytosis processes .

The availability of normalized detection methods using both anti-SYT1 and anti-phospho-SYT1 (Thr202) antibodies allows researchers to determine the ratio of phosphorylated to total SYT1, providing insights into the activation status under different experimental conditions . This differential detection capability is crucial for understanding how neuronal activity and signaling cascades regulate SYT1 function through phosphorylation.

  • What cellular pathways involve SYT1 phosphorylation at Thr202?

Based on the available data, SYT1 phosphorylation at Thr202 appears to be involved in several key neuronal pathways and functions:

  • Calcium-dependent signaling pathways: As SYT1 is a calcium sensor , its phosphorylation at Thr202 likely interacts with calcium-dependent signaling cascades, potentially modifying its calcium sensitivity or binding kinetics.

  • Synaptic vesicle cycling: SYT1 influences both exocytotic and endocytotic components of synaptic transmission , suggesting that Thr202 phosphorylation may regulate vesicle recycling efficiency and availability.

  • Neurotransmitter release: As the primary calcium sensor for synaptic vesicle exocytosis , phosphorylation of SYT1 at Thr202 likely affects neurotransmitter release kinetics, potentially altering synaptic strength and plasticity.

  • Protein kinase pathways: SYT1 can be phosphorylated by multiple protein kinases , suggesting involvement of various kinase cascades that may include PKC, CaMKII, or other neuronal kinases.

For researchers investigating these pathways, using phospho-specific antibodies alongside kinase inhibitors or activators would help elucidate the upstream regulators and downstream effects of SYT1 Thr202 phosphorylation in neuronal function.

Methodology Questions

  • What are the optimal conditions for detecting Phospho-SYT1 (Thr202) in Western blot applications?

For optimal detection of Phospho-SYT1 (Thr202) in Western blot applications, the following conditions are recommended based on manufacturer specifications:

Dilution ratios:

  • 1:1000 for standard Western blot applications

  • 1:500-1:1000 for enhanced sensitivity in certain samples

Sample preparation considerations:

  • Preserving phosphorylation status is critical. Samples should be prepared with phosphatase inhibitors to prevent loss of phosphorylation, as immunolabeling is completely eliminated by λ-phosphatase treatment .

  • Expected molecular weight of phosphorylated SYT1 is approximately 60-62 kDa .

Buffer and blocking conditions:

  • Use standard TBST (Tris-buffered saline with 0.1% Tween-20) for washing steps

  • 5% BSA in TBST is recommended for blocking and antibody dilution rather than milk, as milk contains phosphatases that may reduce signal

Control recommendations:

  • Lambda-phosphatase treatment serves as an effective negative control: "The phosphospecificity of this labeling is shown in the second lane which has been treated with 1200 units Lambda-phosphatase (-phase) for 30 minutes before treatment with anti-phospho-synaptotagmin (T202)" .

Antibody storage:

  • Store at -20°C for up to 1 year, with no need for aliquoting due to the presence of 50% glycerol in storage buffer

These conditions provide a starting point, but optimization for specific experimental systems is recommended for optimal results.

  • How can I validate the specificity of Phospho-SYT1 (Thr202) antibody in my experiments?

Validating antibody specificity is essential for generating reliable research data. For Phospho-SYT1 (Thr202) antibodies, implement the following comprehensive validation approach:

1. Phosphatase Treatment Control:
Lambda phosphatase treatment serves as a definitive negative control, as demonstrated in multiple sources . Treatment with 1200 units of lambda phosphatase for 30 minutes removes phosphate groups from SYT1, completely eliminating signal from a truly phospho-specific antibody.

2. Knockout/Knockdown Validation:
Compare antibody reactivity between wild-type samples and SYT1 knockout or knockdown samples. This approach "using a standardized experimental protocol based on comparing read-outs in knockout cell lines and isogenic parental controls" can definitively establish specificity for the target protein.

3. Peptide Competition Assay:
Several manufacturers produce their antibodies against synthetic phospho-peptides corresponding to amino acid residues surrounding Thr202 . Performing a peptide competition assay with these specific phosphopeptides (sequence R-K-T(p)-L-N) can verify binding specificity.

4. Cross-Methodology Validation:
Cross-validate results using different techniques. Phospho-SYT1 (Thr202) antibodies work in various applications (WB, IHC, ICC, IF, ELISA) , so confirming the same pattern across multiple techniques strengthens confidence in specificity.

5. Molecular Weight Verification:
Confirm signal appears at the expected molecular weight of approximately 62 kDa for SYT1 . Appearance of bands at this molecular weight in control but not phosphatase-treated samples helps validate target specificity.

For high-stakes research, combining multiple validation approaches is strongly recommended to ensure complete confidence in antibody specificity.

  • What fixation protocols work best for immunocytochemistry using Phospho-SYT1 (Thr202) antibodies?

For optimal immunocytochemistry (ICC) results with Phospho-SYT1 (Thr202) antibodies, the following fixation and processing protocol is recommended based on available information:

Fixation Protocol:

  • Paraformaldehyde Fixation: Use 4% paraformaldehyde in PBS for 10-15 minutes at room temperature. This preserves cellular structure while maintaining phospho-epitope integrity.

  • Phosphatase Inhibitor Inclusion: Add phosphatase inhibitors (sodium fluoride 10mM, sodium orthovanadate 1mM, β-glycerophosphate 10mM) to fixation and washing buffers to prevent dephosphorylation during processing.

  • Permeabilization: Gently permeabilize with 0.1-0.3% Triton X-100 for 5-10 minutes to allow antibody access to intracellular antigens.

  • Blocking: Use 3-5% BSA with 5-10% normal serum (from secondary antibody species) to reduce non-specific binding.

Antibody Application:

  • Apply primary antibody at 1:400 dilution as recommended by multiple manufacturers

  • Incubate overnight at 4°C for optimal signal-to-noise ratio

  • Use fluorophore-conjugated secondary antibodies at manufacturer-recommended dilutions (typically 1:500-1:1000)

Controls:

  • Include a lambda phosphatase-treated sample as a negative control

  • Consider dual labeling with a total SYT1 antibody to distinguish phosphorylation changes from expression changes

This protocol should be optimized for specific cell types and experimental conditions. For neuronal cultures, which are the most relevant for SYT1 studies, gentle fixation and processing are particularly important to preserve fine neuronal structures such as synaptic terminals where SYT1 is predominantly localized.

  • How should samples be prepared to preserve Thr202 phosphorylation status in SYT1?

Preserving phosphorylation status is critical when working with phospho-specific antibodies like Anti-Phospho-SYT1 (Thr202). The following comprehensive protocol ensures optimal phospho-epitope preservation:

Immediate Sample Handling:

  • Process tissues or cells immediately after collection or stimulation

  • If immediate processing isn't possible, snap-freeze samples in liquid nitrogen and store at -80°C

Lysis Buffer Composition:
Prepare fresh lysis buffer containing:

  • Base buffer: RIPA or NP-40 buffer (effective for membrane protein extraction)

  • Phosphatase inhibitor cocktail:

    • 50mM sodium fluoride (inhibits serine/threonine phosphatases)

    • 10mM sodium pyrophosphate

    • 1mM sodium orthovanadate (inhibits tyrosine phosphatases)

    • 10mM β-glycerophosphate

    • 1mM EDTA/EGTA (chelates metal ions required by some phosphatases)

  • Protease inhibitor cocktail (to prevent protein degradation)

Sample Processing Conditions:

  • Maintain all extraction steps at 4°C (use ice bath throughout processing)

  • Use cold buffers and pre-chill centrifuges to minimize enzymatic activity

  • Process samples quickly to reduce time for potential dephosphorylation

  • Avoid excessive sonication or mechanical disruption that may generate heat

Sample Storage:

  • If samples cannot be analyzed immediately, add reducing agent and sample buffer

  • Heat-denature samples (95°C for 5 minutes) before storage at -80°C to inactivate enzymes

  • Avoid repeated freeze-thaw cycles that could reactivate phosphatases

Validation Approach:
Include a lambda phosphatase-treated aliquot of your sample as a negative control to confirm phospho-signal specificity, as demonstrated in previous studies .

Following this protocol will help maintain the phosphorylation status of SYT1 at Thr202, ensuring reliable and reproducible results in your experimental applications.

Advanced Research Questions

  • How do different stimulation conditions affect SYT1 Thr202 phosphorylation levels?

The regulation of SYT1 Thr202 phosphorylation by different stimulation conditions represents an active area of research. Based on available information and general principles of neuronal signaling, the following stimulation conditions likely affect SYT1 Thr202 phosphorylation:

Neuronal Activity-Dependent Stimulation:

  • Calcium Influx Modulators: Calcium ionophores (like ionomycin) or depolarizing agents (such as high KCl) likely alter SYT1 phosphorylation, particularly relevant since SYT1 is a calcium sensor protein .

  • Synaptic Activity Induction: Protocols that trigger synaptic activity (electrical stimulation or channelrhodopsin activation in optogenetic systems) may regulate SYT1 phosphorylation as part of activity-dependent synaptic modifications.

Kinase/Phosphatase Pathway Manipulation:

  • Protein Kinase Activators: Since "Synaptotagmin can be phosphorylated by multiple protein kinases" , activators of PKC (PMA), CaMKII, or other neuronal kinases may increase Thr202 phosphorylation.

  • Phosphatase Inhibitors: Okadaic acid, calyculin A, or other phosphatase inhibitors might enhance Thr202 phosphorylation by preventing dephosphorylation.

Methodology for Assessment:
The "Synaptotagmin (phospho Thr202) Cell Based ELISA Kit allows for the detection of Synaptotagmin (phospho Thr202) and the effects that certain stimulation conditions have on Synaptotagmin (phospho Thr202) expression in different cell lines" . This assay system offers a high-throughput approach to evaluate multiple stimulation conditions.

For comprehensive assessment:

  • Use the cell-based ELISA for initial screening of conditions

  • Confirm key findings with Western blotting using phospho-specific antibodies

  • Normalize phospho-SYT1 levels to total SYT1 to distinguish phosphorylation changes from expression changes

  • Include time-course analyses to capture dynamic phosphorylation/dephosphorylation events

This represents an important research direction that could provide insights into the regulatory mechanisms controlling SYT1 function in synaptic transmission.

  • What is the relationship between SYT1 phosphorylation and neurotransmitter release kinetics?

The relationship between SYT1 phosphorylation at Thr202 and neurotransmitter release kinetics represents a complex and mechanistically important aspect of synaptic physiology. Based on available information, several potential functional relationships can be defined:

Mechanistic Implications:

  • Calcium Sensitivity Modulation:
    Since SYT1 functions as "the primary calcium sensor for synaptic vesicle exocytosis" , phosphorylation at Thr202 likely alters its calcium-binding properties. This could shift the calcium concentration threshold required for triggering vesicle fusion, thereby affecting the probability of neurotransmitter release in response to action potentials.

  • Fusion Kinetics Alteration:
    SYT1 "senses calcium influx via its tandem C2-domains, triggering synchronous neurotransmitter release" . Phosphorylation may change the conformation or binding properties of these domains, potentially affecting:

    • The speed of vesicle fusion after calcium influx

    • The synchronicity of neurotransmitter release

    • The temporal precision of synaptic transmission

  • Vesicle Cycling Regulation:
    SYT1 influences "both the exocytotic and endocytotic components of synaptic transmission" . Phosphorylation might affect:

    • The readily releasable pool size of vesicles

    • Vesicle recycling rates following exocytosis

    • The balance between different release modes (synchronous, asynchronous, spontaneous)

Experimental Approaches to Investigate This Relationship:

  • Electrophysiological Studies:

    • Paired-pulse facilitation/depression measurements with phosphomimetic mutants (T202D/E) or phospho-null mutants (T202A)

    • High-frequency stimulation protocols to assess vesicle recycling under phosphorylation changes

    • Miniature excitatory/inhibitory postsynaptic current (mEPSC/mIPSC) analysis to assess quantal release properties

  • Optical Imaging Methods:

    • pHluorin-based assays to visualize vesicle fusion and recycling rates

    • Calcium imaging combined with phosphorylation state manipulation

  • Molecular Techniques:

    • Use of phospho-specific antibodies to correlate phosphorylation levels with electrophysiological measurements

    • Knockout-rescue experiments with phospho-mutant SYT1 variants

Understanding this relationship could provide significant insights into synaptic plasticity mechanisms and potentially reveal new therapeutic targets for neurological disorders associated with synaptic dysfunction.

  • How does SYT1 Thr202 phosphorylation compare across different neuronal cell types or brain regions?

The distribution and regulation of SYT1 Thr202 phosphorylation across different neuronal populations and brain regions represents an important dimension of neuronal specialization. While comprehensive mapping studies are still emerging, several key considerations can guide research in this area:

Regional Expression Patterns:
SYT1 is "Predominantly expressed in rostral, phylogenetically younger brain regions, and in some endocrine tissues" . This baseline expression variation likely influences the abundance and functional significance of phosphorylated SYT1 across brain regions. Based on Western blot data in rat cortex samples , phosphorylated SYT1 at Thr202 is detectable in cortical tissue, suggesting meaningful levels in this region.

Cell Type-Specific Considerations:

  • Excitatory vs. Inhibitory Neurons: Different release properties between these neuronal classes may correlate with distinct SYT1 phosphorylation patterns.

  • Fast-Spiking vs. Regular-Spiking Neurons: Neurons with different firing patterns may employ SYT1 phosphorylation differently to regulate their distinct temporal release characteristics.

  • Central vs. Peripheral: Comparison between central neurons and peripheral synapses (e.g., neuromuscular junction) could reveal specialized regulatory mechanisms.

Methodological Approaches to Study Regional/Cell-Type Variation:

MethodApplicationStrengths
Microdissection + Western BlotRegional comparisonQuantitative assessment of phosphorylation levels relative to total SYT1
ImmunohistochemistryBrain-wide mappingSpatial distribution visualization with cellular resolution
FACS + Phospho-proteomicsCell type-specific analysisIsolation of defined neuronal populations for molecular analysis
Single-cell approachesCellular heterogeneityResolution of cell-to-cell variation within populations

Research Considerations:

  • Correlate phosphorylation with functional properties of different circuits

  • Investigate whether SYT1 phosphorylation correlates with circuit maturation or plasticity

  • Compare regions with different activity levels to determine if SYT1 phosphorylation reflects baseline activity

This research direction has significant potential to reveal how post-translational modifications of synaptic proteins contribute to the functional specialization of different neuronal circuits.

Troubleshooting

  • Why might Phospho-SYT1 (Thr202) antibody show multiple bands in Western blot?

The appearance of multiple bands when using Phospho-SYT1 (Thr202) antibody in Western blotting can arise from several biological and technical factors. Understanding these possibilities is crucial for proper data interpretation:

Biological Sources of Multiple Bands:

  • Isoforms or Splice Variants:
    While the expected molecular weight of phosphorylated SYT1 is approximately 60-62 kDa , SYT1 may exist in multiple isoforms that retain the Thr202 residue but differ in size due to alternative splicing.

  • Post-translational Modifications:
    SYT1 undergoes glycosylation as noted in search result : "Post Translational Modifications: Glycosylated." Different degrees of glycosylation or additional modifications (ubiquitination, SUMOylation) can create higher molecular weight bands of the same protein.

  • SYT1 vs. SYT2 Detection:
    Several antibodies recognize both SYT1 and SYT2 phosphorylated at equivalent positions (Thr202 in SYT1 and Thr199 in SYT2) . These highly homologous proteins may appear as distinct bands.

Technical Sources of Multiple Bands:

  • Proteolytic Degradation:
    Partial degradation during sample preparation might generate fragments that retain the phosphorylated Thr202 epitope, resulting in lower molecular weight bands.

  • Cross-reactivity:
    Despite purification efforts mentioned in multiple sources (e.g., "This antibody was antigen affinity purified from pooled serum" ), some phospho-antibodies may recognize similar phospho-epitopes in other proteins.

Troubleshooting Strategies:

IssueSolutionValidation
DegradationAdd additional protease inhibitors; process samples quicklyBands should disappear with optimized protocol
Cross-reactivityUse blocking peptide competition assaySpecific bands should be competed away by phospho-peptide
Isoforms/PTMsUse phosphatase treatment controlAll phospho-dependent bands should disappear
SYT1 vs. SYT2Use SYT1-specific antibody in parallelCompare band patterns to identify specific proteins

The lambda phosphatase control is particularly valuable as demonstrated in result : "The phosphospecificity of this labeling is shown in the second lane which has been treated with 1200 units Lambda-phosphatase." This treatment should eliminate all genuinely phospho-dependent bands.

Understanding the pattern of bands can provide valuable information about the protein's state and modifications in your experimental system.

  • What controls should be included when investigating phosphorylation dynamics of SYT1?

A comprehensive set of controls is essential when investigating SYT1 phosphorylation dynamics to ensure data reliability and accurate interpretation. The following controls should be included in experimental design:

Essential Controls for Phosphorylation Studies:

  • Phosphatase Treatment Control:
    Lambda phosphatase treatment eliminates signal from phospho-specific antibodies, serving as a definitive negative control: "The phosphospecificity of this labeling is shown in the second lane which has been treated with 1200 units Lambda-phosphatase (-phase) for 30 minutes" . This confirms antibody phospho-specificity.

  • Total SYT1 Control:
    Use "Anti-Synaptotagmin Antibody" alongside phospho-specific antibody to normalize phosphorylation to total protein levels . This crucial control distinguishes between changes in phosphorylation state versus changes in protein expression.

  • Loading Control:
    "Anti-GAPDH Antibody is included to serve as an internal positive control in normalizing the target absorbance values" . This ensures variations aren't due to unequal sample loading.

Advanced Controls for Dynamic Studies:

  • Time Course Samples:
    For phosphorylation dynamics, collect samples at multiple time points (30 sec, 1 min, 5 min, 15 min, 30 min, 1 hr) after stimulation to capture the temporal profile of phosphorylation/dephosphorylation events.

  • Kinase/Phosphatase Modulators:
    Include samples treated with:

    • Kinase inhibitors (specific to suspected upstream kinases)

    • Phosphatase inhibitors (e.g., okadaic acid, calyculin A)
      These help identify enzymes responsible for regulating SYT1 phosphorylation.

  • Unstimulated Baseline:
    Always include unstimulated control samples to establish baseline phosphorylation levels.

Validation Controls:

  • Cell Density Normalization:
    For cell-based assays, "the Crystal Violet whole-cell staining method is used to determine cell density. After staining, the results can be analyzed by normalizing the absorbance values to cell amounts" .

  • Genetic Controls:
    When available, include:

    • SYT1 knockout/knockdown samples (negative control)

    • Phospho-mutant expression (T202A as phospho-null; T202D/E as phospho-mimetic)

Experimental Design Table:

Control TypePurposeAnalysis Method
Phosphatase treatmentVerify phospho-specificityComplete signal elimination
Total SYT1Normalize phospho-signalCalculate phospho/total ratio
Loading control (GAPDH)Ensure equal loadingNormalize signals to GAPDH
Time courseCapture dynamic changesPlot phosphorylation vs. time
Kinase/phosphatase inhibitorsIdentify regulatory enzymesCompare treatment effects

Implementing these controls ensures that observed changes in SYT1 phosphorylation are specific, quantitative, and biologically meaningful.

  • How can I differentiate between Phospho-SYT1 (Thr202) and Phospho-ERK1/2 (Thr202/Tyr204) signals?

The similar nomenclature between Phospho-SYT1 (Thr202) and Phospho-ERK1/2 (Thr202/Tyr204) can create confusion in experimental design and data interpretation. Here's a systematic approach to differentiate between these distinct phosphorylated proteins:

Key Differentiating Characteristics:

  • Molecular Weight Differences:

    • Phospho-SYT1 appears at ~60-62 kDa

    • Phospho-ERK1/2 appears as a doublet at 42 and 44 kDa (p42/p44 MAPK)

    This substantial molecular weight difference (>15 kDa) provides the most reliable way to distinguish between these proteins on Western blots.

  • Phosphorylation Epitope:

    • Phospho-SYT1 antibodies recognize a single phosphorylated threonine (Thr202)

    • Phospho-ERK1/2 antibodies recognize a dual phosphorylation motif (Thr202/Tyr204)

  • Immunogen Sequence Differences:

    • For Phospho-SYT1, the immunogen peptide sequence is "R-K-T(p)-L-N"

    • For Phospho-ERK1/2, the recognition sequence includes both Thr202 and Tyr204 phosphorylation sites

Experimental Strategies for Differentiation:

StrategyImplementationExpected Outcome
Molecular weight analysisRun protein standards alongside samplesSYT1 at ~62 kDa; ERK1/2 at 42/44 kDa
Specific activatorsTreat samples with EGF or PMA (activates ERK pathway)Increased p-ERK1/2 but not necessarily p-SYT1
Pathway inhibitorsUse MEK inhibitors (U0126/PD98059)Blocks ERK1/2 phosphorylation without directly affecting SYT1
Antibody validationUse blocking peptides specific to each phospho-epitopeEach antibody should be blocked only by its specific peptide

Practical Recommendations:

  • Sequential Probing: Strip and reprobe membranes with antibodies against both phospho-proteins to verify distinct molecular weights.

  • Specific Controls: Include recombinant phosphorylated proteins or peptides as positive controls.

  • Tissue Distribution: While both proteins may be present in neuronal samples, ERK1/2 is ubiquitously expressed across tissues, whereas SYT1 is predominantly expressed in neural and some endocrine tissues .

  • Alternative Antibody Clones: If possible, use antibodies from different manufacturers that have been extensively validated for specificity.

By implementing these strategies, researchers can confidently distinguish between these two distinct phosphorylated proteins despite the similar numbering of their phosphorylation sites.

Comparative Analysis

  • How do phospho-specific antibodies for SYT1 compare to proximity ligation assays for detecting phosphorylation events?

Phospho-specific antibodies and proximity ligation assays (PLA) represent two distinct methodological approaches for studying SYT1 phosphorylation, each with unique advantages for different research questions:

Phospho-specific Antibodies for SYT1 (Thr202):

AdvantagesLimitations
Versatility: Can be used in multiple applications including Western blot, immunohistochemistry, immunocytochemistry, ELISA, and flow cytometry Background Issues: May show non-specific binding requiring extensive validation
Quantification: Western blotting allows semi-quantitative analysis of phosphorylation levels across samplesBinary Detection: Detects presence/absence of phosphorylation but doesn't inherently provide information about protein interactions
Single-antibody Approach: Only requires the phospho-specific antibody, simplifying experimental designThreshold Dependence: May miss low levels of phosphorylation depending on antibody sensitivity
Established Protocols: Well-defined protocols with specific dilution recommendations (e.g., 1:1000 for WB) Post-lysis Artifacts: Sample processing may alter phosphorylation status

Proximity Ligation Assay for Phosphorylation Detection:

AdvantagesLimitations
Enhanced Specificity: Requires two antibodies in close proximity (one for SYT1, one for phospho-epitope), reducing false positivesTechnical Complexity: More complex protocol than standard antibody-based methods
Signal Amplification: Rolling circle amplification provides signal enhancement, potentially detecting lower phosphorylation levelsRequires Two Compatible Antibodies: Needs both anti-SYT1 and anti-phospho antibodies that don't interfere with each other
In situ Detection: Visualizes phosphorylation events in intact cells with precise subcellular localizationPrimarily Qualitative: Though dot counting is possible, quantification is typically less precise than Western blotting
Protein Interaction Studies: Can be adapted to study interactions between phosphorylated SYT1 and binding partnersHigher Cost: More expensive reagents and typically more time-consuming

Decision Framework for Method Selection:

  • For Initial Characterization:
    Phospho-specific antibodies in Western blot provide the most straightforward approach to detect and quantify SYT1 phosphorylation at Thr202.

  • For Subcellular Localization:

    • Standard immunofluorescence with phospho-antibodies provides good resolution

    • PLA offers enhanced specificity when background is problematic

  • For Protein Interaction Studies:
    PLA is superior for investigating whether phosphorylated SYT1 interacts with specific binding partners in intact cells.

  • For Quantitative Comparisons:
    Western blotting with phospho-specific antibodies, normalized to total SYT1, provides the most reliable quantitative comparison across experimental conditions.

The complementary use of both approaches—phospho-specific antibodies for quantification and broad characterization, followed by PLA for validation and interaction studies—represents an optimal strategy for comprehensive investigation of SYT1 phosphorylation dynamics.

  • What are the advantages and limitations of using Phospho-SYT1 cell-based ELISA versus traditional Western blot?

The choice between Phospho-SYT1 (Thr202) cell-based ELISA and traditional Western blotting involves important methodological tradeoffs that impact experimental design and data interpretation. The following comprehensive comparison highlights the strengths and limitations of each approach:

Phospho-SYT1 Cell-Based ELISA Advantages:

  • Higher Throughput:
    The plate format enables testing multiple samples and conditions simultaneously, making it ideal for "detection of Synaptotagmin (phospho Thr202) and the effects that certain stimulation conditions have on Synaptotagmin (phospho Thr202) expression in different cell lines" .

  • Quantitative Precision:
    ELISA provides more precise quantification compared to densitometry of Western blot bands, with lower coefficient of variation between replicates.

  • Integrated Normalization:
    Multiple normalization methods are built into the assay system: "Anti-GAPDH Antibody is included to serve as an internal positive control" and "the Crystal Violet whole-cell staining method is used to determine cell density" .

  • In-situ Detection:
    Cell-based ELISA detects phosphorylation in intact fixed cells, maintaining cellular context and potentially preserving labile modifications that might be lost during cell lysis.

  • Streamlined Workflow:
    Eliminates time-consuming gel electrophoresis, transfer, and extended incubation steps required for Western blotting.

Phospho-SYT1 Cell-Based ELISA Limitations:

  • Qualitative Nature:
    The "qualitative nature of this Synaptotagmin (phospho Thr202) Cell Based ELISA Kit" suggests it may not provide absolute quantification.

  • No Molecular Weight Verification:
    Unlike Western blot, ELISA cannot verify antibody specificity based on molecular weight, increasing the importance of antibody validation.

  • Limited Sample Types:
    Cell-based ELISA is optimized for cultured cells but not directly applicable to tissue samples or subcellular fractions.

  • Less Information About Protein State:
    Western blot can reveal multiple bands representing different isoforms or modification states, while ELISA provides only total signal intensity.

Traditional Western Blot Advantages:

  • Molecular Weight Confirmation:
    Western blotting reveals the molecular weight of detected proteins (~60-62 kDa for phosphorylated SYT1 ), providing crucial specificity validation.

  • Multiple Protein States:
    Can distinguish between different forms of SYT1 (potential isoforms, degradation products, or differently modified versions).

  • Flexible Sample Types:
    Applicable to diverse sample types including tissue homogenates, subcellular fractions, and immunoprecipitates.

  • Direct Visualization:
    Provides visual confirmation of specific antibody binding and allows assessment of non-specific binding.

Traditional Western Blot Limitations:

  • Lower Throughput:
    Processing multiple samples requires running multiple gels or very large gels.

  • Semi-Quantitative:
    Densitometry analysis is less precise than ELISA readouts, with higher variability between replicates.

  • Time-Intensive:
    Requires multiple steps (electrophoresis, transfer, blocking, antibody incubations) across 1-2 days.

  • Sample Processing Artifacts:
    Cell lysis and protein denaturation may affect phospho-epitope detection or introduce artifactual changes.

Methodological Selection Table:

Research PurposeRecommended MethodKey Consideration
Screening multiple conditionsCell-based ELISAHigher throughput, standardized protocol
Initial phospho-epitope validationWestern blotMolecular weight confirmation essential
In situ phosphorylation detectionCell-based ELISAPreserves cellular context
Detecting multiple protein formsWestern blotCan visualize different protein states
Comparing effects across cell typesCell-based ELISAStandardized quantification across samples
Tissue sample analysisWestern blotCompatible with tissue homogenates

For many research applications, a complementary approach using both methodologies provides the most comprehensive characterization of SYT1 phosphorylation dynamics.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.